SPR Therapeutics has developed a peripheral nerve stimulation system that is placed percutaneously through the skin instead of being implanted and which can be completely removed from the body after therapy period.
Cleveland-based medical device company SPR Therapeutics has upped its series A yet again and raised an additional $2.8 million, which brings its total to $5 million from NDI Healthcare Fund, Public Square Partners and individual investors. CEO Maria Bennett said the funding will help the company commercialize its peripheral nerve stimulation technology platform. The […]
A new report from Relatient, A Data-Driven Guide to Patient Access Succes, highlights how focusing on data accuracy and relevance can enhance the performance of healthcare practices.
A minimally invasive device to relieve shoulder pain after stroke is heading to phase 3 trials by the end of this year. SPR Therapeutics has been cleared by the FDA to begin a pivotal study of its Smartpatch Peripheral Nerve Stimulation System. According to CEO Maria Bennett, the randomized, placebo-controlled study will test for safety […]
Neurostimulation pain-relief device company SPR Therapeutics has been approved for a $900,000 loan from the state of Ohio. The financing comes after Cleveland-area SPR earlier this year raised a $2.2 million series A round and announced that it was on the hunt for strategic partnerships that could range from licensing deals to outright acquisition. A […]
Neurostimulation pain-relief device company SPR Therapeutics has raised its series A round of investment to $2.2 million. The Cleveland-area company, whose pain-relief system is aimed at reducing shoulder pain in patients who’ve suffered strokes, has also engaged an investment banking firm to look for strategic partnerships, CEO Maria Bennett said. SPR is “very flexible” in […]
Neurostimulation startup SPR Therapeutics has reached an important milestone, implanting its post-stroke shoulder-pain device in a patient for the first time. A 76-year-old man suffering from shoulder pain is now pain-free after being implanted with the device at Carolinas Medical Center in Charlotte, North Carolina. The patient also reported a better quality of life, with […]
When it comes to managing inbound phone calls, underperformance has devastating cost implications.
Neurotechnology pain-relief device company SPR Therapeutics has increased its series A round of investment to $1 million and hopes to push the number up to $2 million, according to a regulatory document. CEO Maria Bennett said earlier this year that Cleveland-area SPR was targeting a $2 million round to beef up its sales and marketing […]
Neurostimulation company SPR Therapeutics has received a $250,000 investment from JumpStart to help develop and commercialize its pain relief medical device. SPR’s first product, the minimally invasive Smartpatch, is aimed at reducing shoulder pain in patients who’ve suffered strokes. The technology works via an external generator that electrically stimulates a peripheral nerve to exercise a […]
Assuming all goes well in a federal regulatory review, neurotechnology startup SPR Therapeutics expects to begin commercializing its first product, a pain relief device, by the end of the year. Year-old SPR (it stands for “stimulation for pain relief”) is one of the newest members of the Cleveland area’s growing cluster of neurotechnology firms. The […]
Cleveland Clinic neuromodulation spinoff Intelect Medical may have stealthily exited Cleveland to set up shop in Boston, but the company's recent $78 million sale to Boston Scientific (NYSE: BSX) highlights Northeast Ohio's growing strength in neurotechnology. Here's a brief overview of the key players in Northeast Ohio's rising neurotechnology industry.
The progress in artificial intelligence (AI) is reshaping patient care, across various dimensions, from facilitating faster discharge to curating treatment plans and suggesting lifestyle changes.
Maria Bennett has never been your generic biomedical engineer. Now, she's also the chief executive of a company working to develop and market a neurostimulation device aimed at alleviating shoulder pain for stroke patients.
NDI Medical LLC has raised $2.1 million to continue developing nerve-stimulating devices to answer patient needs and improve their health care. The Highland Hills company recently spun out two technologies -- one identifies nerves and muscles during surgery; the other stimulates nerves to relieve chronic pain.